Dr. rer. nat. Katja Schmidt

List of publications:

BibTeX-Download


Department of Medicine 3 – Rheumatology and Immunology
close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

PRE-EXPOSURE PROPHYLAXIS FOR SARS-COV-2 INFECTION WITH SUBCUTANEOUS CASIRIVIMAB/IMDEVIMAB IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES. (2022) Fagni F, Schmidt K, Bohr D, Valor L, Hartmann F, Tascilar K, Manger K, et al. Conference contribution Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination (2022) Fagni F, Schmidt K, Bohr D, Valor-Mendez L, Tascilar K, Manger K, Manger B, et al. Journal article, Letter Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection (2022) Schmidt K, Harrer E, Tascilar K, Kuebel S, El Kenz B, Simon D, Schett G, et al. Journal article, Original article Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease (2021) Simon D, Tascilar K, Fagni F, Schmidt K, Krönke G, Kleyer A, Ramming A, et al. Journal article SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses (2021) Schmidt K, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, et al. Journal article SARS-CoV-2-seronegative HIV-1-infected subjects target CTL epitopes in the SARS-CoV-2 nucleoprotein cross-reactive to common cold coronaviruses (2021) Schmidt K, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, et al. Conference contribution
‹ 1 2 ›